Prenatal diagnosis of Niemann-Pick type C disease: current strategy from an experience of 37 pregnancies at risk.
Thirty-seven pregnancies at risk for Niemann-Pick type C disease were monitored by study of cultured amniotic fluid cells (8 cases) or chorionic villus cells (29 cases) in 23 couples over the period 1984-91. An early protocol combined determination of sphingomyelinase activity with electron microscopy. The current strategy, based on the demonstration of specific abnormalities in intracellular processing of exogenous cholesterol, combines the study of the early phase (first 6 h) of LDL-induced cholesteryl ester formation and the histochemical evaluation (filipin staining after 24 h of LDL uptake) of the LDL-induced accumulation of unesterified cholesterol. Thirteen fetuses were predicted to be affected. Confirmation of the diagnosis was made by study of cholesterol processing in fetal skin fibroblast cultures and/or by demonstration of a characteristic lipid storage in fetal liver, already present at 14 w gestation. Definition of the biochemical phenotype (classical, variant, or intermediate) of the index case, with regard to cholesterol-processing abnormalities, is an absolute prerequisite to adequate genetic counseling in a given family. Prenatal diagnosis has now proved a safe procedure in the predominant (approximately 85%) group of families with the classical phenotype.
Vanier
M T
MT
Fondation Gillet-Mérieux, Lyon-Sud University Hospital, France.
Rodriguez-Lafrasse
C
C
Rousson
R
R
Mandon
G
G
Boué
J
J
Choiset
A
A
Peyrat
M F
MF
Dumontel
C
C
Juge
M C
MC
Pentchev
P G
PG
D002478:Cells, Cultured; D002784:Cholesterol / Q000378:metabolism; D002788:Cholesterol Esters / Q000378:metabolism; D005260:Female; D005817:Genetic Counseling; D006801:Humans; D009542:Niemann-Pick Diseases / Q000175:diagnosis* / Q000235:genetics / Q000378:metabolism; D011247:Pregnancy; D011296:Prenatal Diagnosis; D013108:Sphingomyelin Phosphodiesterase / Q000378:metabolism
D002788:Cholesterol Esters; D002784:Cholesterol; D013108:Sphingomyelin Phosphodiesterase